🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07143825
Recruiting Observational

A National Multicenter Survey on Small Vulnerable Newborns

NCT07143825 · tracked via the Priya Life Science China tracker
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2025-04-01
Last updated
2025-08-27

Condition(s) studied

PretermSmall Gestational Age (SGA)

Study summary

The goal of this nationwide multicenter observational study is to comprehensively investigate the severity of Small Vulnerable Newborns (SVN) issues across China and to propose further preventive and intervention measures. The primary aim is to provide a thorough description of SVN problems using a unified definition and framework, and to develop targeted prevention strategies.

Participating centers across the country will collect clinical data on vulnerable newborns under their care and complete detailed questionnaires to support this research.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Newborns diagnosed as vulnerable infants at the participating hospitals between January 1 and December 31, 2024; 2. Meeting any one of the following criteria: * Diagnosed as small for gestational age (SGA): birth weight below the 10th percentile for infants of the same gestational age and sex; * Preterm infants: gestational age less than 37 weeks; * Low Birth Weight (LBW) infants: birth weight less than 2,500 grams. Exclusion Criteria: * Incomplete medical records due to missing data preventing comprehensive case evaluation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality Recruiting

More Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07143825 on ClinicalTrials.gov ↗ ← All trials in China